Sandoz announces successor to retiring president of Region International

Swiss generic and biosimilars drugmaker Sandoz (SIX: SDZ) today revealed that Francisco Ballester, president Region International and a member of the Sandoz executive committee, will retire and step down from the SEC on March 1, 2025.

Since 2019, Mr Ballester has been responsible in this role for driving business growth and access for patients in markets outside of North America and Europe, while developing highly diverse talents in the region. He is a member of the health management and policy advisory council of the Miami Herbert Business School.

Drawing on a strong bench of internal leaders, Peter Stenico will succeed Mr Ballester. Mr Stenico was appointed global platform head, Biosimilars in January 2023 and has led the Sandoz global biosimilar strategy. Previously, he held the position of country head and general manager for Sandoz in Germany and was also the former president of the German Generics Association (Pro Generika). Mr Stenico joined Sandoz in 2002 and has gained vast biosimilars and generics industry experience through various roles covering strategy, M&A and commercial at global, regional and local levels.